CompletedNot Applicable

ADIE-BC - Aligning Dimensions of Interoceptive Experience in Breast Cancer Survivors

United Kingdom21 participantsStarted 2025-06-13

Plain-language summary

A breast cancer diagnosis can lead to significant anxiety, and for many survivors, this anxiety continues well beyond the end of treatment. While standard anxiety therapies are helpful for some, these therapies often fall short for breast cancer survivors due to an individual's unique experience-particularly changes in how survivors perceive and relate to the body, a process known as interoception. The study will evaluate the feasibility and acceptability of a novel interoceptive training approach called ADIE Therapy. ADIE Therapy trains participants to better recognise bodily signals, and has shown promising results in reducing anxiety in non-cancer populations. The aim of the study is to assess the acceptability and feasibility of ADIE Therapy for breast cancer survivors.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years old or older * Residing in the UK and able to travel into London * Can read and write in English * Have had a diagnosis of Primary Breast Cancer * Have completed active, hospital-based treatment for primary breast cancer (Stages 1, 2 or 3; this refers to radiotherapy, surgery, or chemotherapy) 6 months - 10 years previously (this does not apply to ongoing endocrine (hormone) therapy) Exclusion Criteria: * Currently taking medication for cardiac arrhythmia (e.g., beta blockers) * Currently in active treatment for breast cancer and/or other types of cancer * Currently pregnant

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Acceptability of the Intervention - Theoretical Framework of Acceptability (TFA) Questionnaire

Timeframe: Post-Treatment (Week 7)

Feasibility and Acceptability of the Intervention - Qualitative Interview

Timeframe: Post-Treatment (Week 7)

Acceptability of the Intervention - Net Promoter Score

Timeframe: Post-Treatment (Week 7)

Feasibility of the Study - Participant Retention

Timeframe: Baseline through Post-Treatment (Week 7)

Feasibility of the Study - Session Adherence

Timeframe: Baseline through Post-Treatment (Week 7)

Trial details

NCT IDNCT06954532

SponsorKing's College London

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-18

View on ClinicalTrials.gov More Cancer trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Acceptability of the Intervention - Theoretical Framework of Acceptability (TFA) Questionnaire

Timeframe: Post-Treatment (Week 7)

Feasibility and Acceptability of the Intervention - Qualitative Interview

Timeframe: Post-Treatment (Week 7)

Acceptability of the Intervention - Net Promoter Score

Timeframe: Post-Treatment (Week 7)

Feasibility of the Study - Participant Retention

Timeframe: Baseline through Post-Treatment (Week 7)

Feasibility of the Study - Session Adherence

Timeframe: Baseline through Post-Treatment (Week 7)